Figure. 2
From: Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients
Expression levels of CA15-3, CEA, and SF in serum of canine mammary tumor. (a) Serum CA15-3 levels of malignant tumor group, benign tumor group, and healthy control group. (b) Serum CEA levels of the three groups. (c) Serum SF levels of the three groups. Note: * P < 0.05 showed significance difference, ** P < 0.01 showed extremely significant difference vs control group; # P < 0.05 showed significance difference, ## P < 0.01 showed extremely significant difference vs benign mammary gland tumor group.
